AC Immune (ACIU) Cash from Investing Activities (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.36% |
| Sep 30, 2025 | -10.61% |
| Jun 30, 2025 | 756.56% |
| Mar 31, 2025 | 177.11% |
| Dec 31, 2024 | -81.31% |
| Sep 30, 2024 | 97.13% |
| Jun 30, 2024 | -210.58% |
| Mar 31, 2024 | -202.85% |
| Dec 31, 2023 | 391.13% |
| Sep 30, 2023 | 193.21% |
| Jun 30, 2023 | -112.39% |
| Mar 31, 2023 | 798.95% |
| Dec 31, 2022 | 197.08% |
| Sep 30, 2022 | -120.87% |
| Jun 30, 2022 | 4,444.30% |
| Mar 31, 2022 | 97.52% |
| Dec 31, 2021 | -4,269.64% |
| Sep 30, 2021 | 98.40% |
| Jun 30, 2021 | -3,747.61% |
| Mar 31, 2021 | -118.96% |
| Dec 31, 2020 | -71.24% |
| Sep 30, 2020 | 60.42% |
| Jun 30, 2020 | 4,657.51% |
| Mar 31, 2020 | 96.11% |
| Dec 31, 2019 | 46.90% |
| Sep 30, 2019 | -3,039.23% |
| Jun 30, 2019 | 99.33% |
| Mar 31, 2019 | -66.43% |
| Dec 31, 2018 | -21,469.96% |
| Sep 30, 2018 | 66.08% |
| Jun 30, 2018 | 65.94% |
| Mar 31, 2018 | -100.07% |
| Dec 31, 2017 | 197.51% |
| Sep 30, 2017 | -203,294.81% |
| Jun 30, 2017 | -46.75% |
| Mar 31, 2017 | -123.22% |
| Dec 31, 2016 | 8.82% |
| Sep 30, 2016 | -213.78% |
| Jun 30, 2016 | 52.72% |
| Mar 31, 2016 | -4,084.98% |